Linda Louie - Amgen VP Officer
| AMG Stock | EUR 251.40 1.80 0.71% |
Insider
Linda Louie is VP Officer of Amgen Inc
| Phone | 805 447 1000 |
| Web | https://www.amgen.com |
Amgen Management Efficiency
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Cristina Wilbur | Roche Holding Ltd | 56 | |
| Natacha Gassenbach | Biogen Inc | N/A | |
| Nicole Murphy | Biogen Inc | N/A | |
| William Anderson | Roche Holding Ltd | 57 | |
| Johannes MD | Roche Holding Ltd | 66 | |
| Ginger Gregory | Biogen Inc | 55 | |
| Michael CPA | Biogen Inc | 59 | |
| Robin Kramer | Biogen Inc | 57 | |
| Thomas Schinecker | Roche Holding Ltd | 48 | |
| Barbara Schadler | Roche Holding Ltd | 61 | |
| Sanjay Jariwala | Biogen Inc | N/A | |
| Bruno Eschli | Roche Holding Ltd | N/A | |
| Anabella Villalobos | Biogen Inc | 64 | |
| Claudia Bockstiegel | Roche Holding Ltd | 59 | |
| Severin Schwan | Roche Holding Ltd | 56 | |
| Christopher Viehbacher | Biogen Inc | 63 | |
| Alan Hippe | Roche Holding Ltd | 56 | |
| Pascale Schmidt | Roche Holding Ltd | 50 | |
| Michael Hencke | Biogen Inc | N/A | |
| Susan Esq | Biogen Inc | 66 | |
Management Performance
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 |
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Linda Louie, VP Officer | ||
| Norbert Quinkert, Member of the Supervisory Board | ||
| Steve Daniels, Vice President Investor Relations | ||
| Dagmar Bottenbruch, Independent Member of the Supervisory Board | ||
| Donatella Ceccarelli, Independent Member of the Supervisory Board | ||
| Nancy Grygiel, Sr Officer | ||
| Martin Hoyos, Member of the Supervisory Board | ||
| Willem Hassel, Independent Vice Chairman of the Supervisory Board | ||
| Frank Lohner, Independent Member of the Supervisory Board | ||
| Herbert Depp, Independent Member of the Supervisory Board | ||
| Esteban Santos, Ex Operations | ||
| Heinz Schimmelbusch, Chairman of the Management Board, Chief Executive Officer | ||
| Eric Jackson, Member of the Management Board and Presidentident of the AMG Processing Division, COO | ||
| Jonathan Graham, Gen VP | ||
| Mike Zahigian, VP Officer | ||
| Arvind Sood, VP Relations | ||
| Robert Bradway, CEO Chairman | ||
| Suzanne Folsom, Member of the Supervisory Board | ||
| Peter Griffith, Ex CFO | ||
| Murdo Gordon, Ex Operations | ||
| Petteri Soininen, Member of the Supervisory Board | ||
| Jack Messman, Vice Chairman of Supervisory Board | ||
| Amy Ard, CFO | ||
| Steve Hanke, Independent Chairman of the Supervisory Board | ||
| Jackson Dunckel, Member of the Management Board, Chief Financial Officer | ||
| Michele Fischer, Vice President IR Contact Officer | ||
| Guy Moranville, Member of the Supervisory Board | ||
| Robert Meuter, Member of the Supervisory Board | ||
| David MD, Ex RD | ||
| Mike Connor, Senior Vice President and Corporate Controller |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.38 % | |||
| Current Valuation | 163.09 B | |||
| Shares Outstanding | 533.98 M | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 79.91 % | |||
| Price To Earning | 17.42 X | |||
| Price To Book | 38.95 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amgen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amgen's short interest history, or implied volatility extrapolated from Amgen options trading.
Pair Trading with Amgen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Moving together with Amgen Stock
| 0.69 | BAYN | Bayer AG NA | PairCorr |
Moving against Amgen Stock
| 0.83 | WMT | Walmart Split | PairCorr |
| 0.83 | WMT | Walmart Split | PairCorr |
| 0.73 | AMZ | Amazon Inc | PairCorr |
| 0.73 | DBPE | Xtrackers LevDAX | PairCorr |
| 0.71 | AMZ | Amazon Inc | PairCorr |
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |